A Swiss chapter · Est. 2026
Growing the next generation of biologics.
Exploring innovative approaches to sustainable biologic manufacturing, recombinant proteins, and next-generation therapeutic production technologies.
02 — Vision
A new chapter for Innovetica.
Innovetica is entering a new era focused on biotechnology, sustainability, and innovative approaches to biologic manufacturing.
Our vision is to explore technologies that may contribute to making biologic therapies more affordable, environmentally responsible, and accessible to broader populations.
- 01
Sustainable Biologics
Lower-footprint pathways for next-generation therapeutic production.
- 02
Recombinant Proteins
Engineered expression for purity, yield and translational fit.
- 03
Antibody Production
Exploring scalable routes for monoclonal and novel antibody formats.
- 04
Plant-Based Expression
Botanical systems as living bioreactors for complex biologics.
- 05
Vertical Farming
Controlled-environment cultivation as a bio-manufacturing substrate.
- 06
Biotechnology Innovation
Cross-disciplinary methods bridging biology, engineering and design.
03 — Why it matters
The future of biologics.
Biologic medicines have transformed the treatment of many serious diseases. However, manufacturing remains expensive and resource intensive.
Innovetica explores alternative production technologies that have the potential to improve sustainability, scalability, and accessibility.
Sustainability
Lower resource, lower waste
Scalability
Modular, distributed capacity
Accessibility
Broader patient reach
Innovation
Open scientific inquiry
04 — Main Platform
Discover the full vision.
Visit our primary platform to learn more about Innovetica's vision, projects, and future developments.